Insight Pharma Announces Commercializing Biomarkers in Therapeutic and Diagnostic Applications

May 26, 2011 - PRLog -- NEEDHAM, MASS. –  Cambridge Healthtech Institute’s Insight Pharma Reports announces the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report, Authored by Lucy Sannes, MBA, PhD.

Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing knowledge about biomarkers and successfully commercialize them in therapeutic and diagnostic applications.

Included in this publication:

•   Biomarker definitions and guidelines for their development and validation
•   Applications of biomarkers in oncology, cardiology, neurology, drug safety, and other areas
•   Selected companies in the biomarker research products/ tools and services market
•   Strategies for successful commercialization of biomarkers in the therapeutics and diagnostics          markets
•   Forty key companies to watch, plus the activities of 175 companies that are commercializing biomarkers and/or systems for their detection and measurement
•   Expert interviews

Expert interviews included are:

•   Sriram Balasubramanian, PhD, Senior Director, Translational Medicine, Pharmacyclics  
•   Barbara Conley, MD, Associate Director, Cancer Diagnosis Program, National Cancer Institute
•   Felix W. Frueh, PhD, Vice President, Research & Development, Personalized Medicine, Medco Health Solutions
•   William N. Hait, MD, Senior Vice President and Worldwide Head of Oncology and Hematology R&D, Johnson & Johnson
•   Francis Kalush, PhD, Diagnostics & Personalized Medicine Network Leader, Office of the Center Director, Center for Devices and Radiological Health (CDRH), US Food & Drug Administration (FDA)
•   Paul Kearney, PhD, Founder, President, & CSO, Integrated Diagnostics
•   Martin LeBlanc, President and CEO, Caprion Proteomics  
•   Michael Liebman, PhD, Managing Director, Strategic Medicine
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com

About Insight Pharma Reports (http://InsightPharmaReports.com)
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  www.InsightPharmaReports.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.